Search Results - "Weiner, Adam B"

Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure by Premi, Sanjay, Wallisch, Silvia, Mano, Camila M., Weiner, Adam B., Bacchiocchi, Antonella, Wakamatsu, Kazumasa, Bechara, Etelvino J. H., Halaban, Ruth, Douki, Thierry, Brash, Douglas E.

“…Mutations in sunlight-induced melanoma arise from cyclobutane pyrimidine dimers (CPDs), DNA photoproducts that are typically created picoseconds after an…”
Get full text

Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes by Weiner, Adam B., Vidotto, Thiago, Liu, Yang, Mendes, Adrianna A., Salles, Daniela C., Faisal, Farzana A., Murali, Sanjana, McFarlane, Matthew, Imada, Eddie L., Zhao, Xin, Li, Ziwen, Davicioni, Elai, Marchionni, Luigi, Chinnaiyan, Arul M., Freedland, Stephen J., Spratt, Daniel E., Wu, Jennifer D., Lotan, Tamara L., Schaeffer, Edward M.

“…Black men die more often of prostate cancer yet, interestingly, may derive greater survival benefits from immune-based treatment with sipuleucel-T. Since no…”
Get full text

A PRC2-independent function for EZH2 in regulating rRNA 2′-O methylation and IRES-dependent translation by Yi, Yang, Li, Yanqiang, Meng, Qingshu, Li, Qiaqia, Li, Fuxi, Lu, Bing, Shen, Jiangchuan, Fazli, Ladan, Zhao, Dongyu, Li, Chao, Jiang, Weihua, Wang, Rui, Liu, Qipeng, Szczepanski, Aileen, Li, Qianru, Qin, Wei, Weiner, Adam B., Lotan, Tamara L., Ji, Zhe, Kalantry, Sundeep, Wang, Lu, Schaeffer, Edward M., Niu, Hengyao, Dong, Xuesen, Zhao, Wei, Chen, Kaifu, Cao, Qi

“…Dysregulated translation is a common feature of cancer. Uncovering its governing factors and underlying mechanism are important for cancer therapy. Here, we…”
Get full text

Insurance coverage, stage at diagnosis, and time to treatment following dependent coverage and Medicaid expansion for men with testicular cancer by Weiner, Adam B, Jan, Stephen, Jain-Poster, Ketan, Ko, Oliver S, Desai, Anuj S, Kundu, Shilajit D

“…Introduction We sought to assess the impact of Affordable Care Act Dependent Care Expansion (ACA-DCE), which allowed dependent coverage for adults aged 19-25,…”
Get full text

Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors by Smith, Norm D, Prasad, Sandip M, Patel, Amit R, Weiner, Adam B, Pariser, Joseph J, Razmaria, Aria, Maene, Chieko, Schuble, Todd, Pierce, Brandon, Steinberg, Gary D

“…Purpose We assessed the association of temporal, socioeconomic and environmental factors with bladder cancer mortality in the United States. Our hypothesis was…”
Get full text

Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013) by Weiner, Adam B., Keeter, Mary-Kate, Manjunath, Adarsh, Meeks, Joshua J.

“…We sought to characterize national disparities in the diagnosis of advanced stage bladder cancer. Among patients with advanced disease, we explored disparities…”
Get full text

A novel prostate cancer subtyping classifier based on luminal and basal phenotypes by Weiner, Adam B., Liu, Yang, Hakansson, Alex, Zhao, Xin, Proudfoot, James A., Ho, Julian, Zhang, JJ H., Li, Eric V., Karnes, R. Jeffrey, Den, Robert B., Kishan, Amar U., Reiter, Robert E., Hamid, Anis A., Ross, Ashely E., Tran, Phuoc T., Davicioni, Elai, Spratt, Daniel E., Attard, Gerhardt, Lotan, Tamara L., Lee Kiang Chua, Melvin, Sweeney, Christopher J., Schaeffer, Edward M.

“…Background Prostate cancer (PCa) is a clinically heterogeneous disease. The creation of an expression‐based subtyping model based on prostate‐specific…”
Get full text

Predictors of use and overall survival for patients undergoing metastasectomy for bladder cancer in a national cohort by Weiner, Adam B, Pham, Minh N, Isaacson, Dylan S, Ko, Oliver S, Breen, Kieran J, Nadler, Robert B

“…Objectives To determine the use of surgical resection of metastatic disease in a large national sample and its association with overall survival. Methods The…”
Get full text

Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases by Wenger, Hannah, M.D, Weiner, Adam B., M.D, Razmaria, Aria, M.D, Paner, Gladell P., M.D, Eggener, Scott E., M.D

“…Abstract Introduction Several institutional studies have suggested that pathological Gleason score≤6 prostate cancer has little or no capacity for metastasis…”
Get full text

Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States by Weiner, Adam B., B.S, Patel, Sanjay G., M.D, Eggener, Scott E., M.D

“…Abstract Objectives To measure adverse pathologic outcomes following radical prostatectomy (RP) for men with low-risk prostate cancer in the United States…”
Get full text

Radiographic hemithorax white-out following percutaneous nephrolithotomy by Zhu, Alec, Weiner, Adam B., Nadler, Robert B.

Get full text

n = 1 by Weiner, Adam B.

Get full text

National Trends in the Management of Low and Intermediate Risk Prostate Cancer in the United States by Weiner, Adam B, Patel, Sanjay G, Etzioni, Ruth, Eggener, Scott E

“…Purpose To our knowledge factors affecting the adoption of noncurative initial management in the United States for low risk prostate cancer on a population…”
Get full text

Cause of death during prostate cancer survivorship: A contemporary, US population–based analysis by Weiner, Adam B., Li, Eric V., Desai, Anuj S., Press, David J., Schaeffer, Edward M.

“…BACKGROUND More than 3.6 million men in the United States harbor a diagnosis of prostate cancer (PCa). The authors sought to provide in‐depth analyses of the…”
Get full text

A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer by Jairath, Neil K., Dal Pra, Alan, Vince, Randy, Dess, Robert T., Jackson, William C., Tosoian, Jeffrey J., McBride, Sean M., Zhao, Shuang G., Berlin, Alejandro, Mahal, Brandon A., Kishan, Amar U., Den, Robert B., Freedland, Stephen J., Salami, Simpa S., Kaffenberger, Samuel D., Pollack, Alan, Tran, Phuoc, Mehra, Rohit, Morgan, Todd M., Weiner, Adam B., Mohamad, Osama, Carroll, Peter R., Cooperberg, Matthew R., Karnes, R. Jeffrey, Nguyen, Paul L., Michalski, Jeff M., Tward, Jonathan D., Feng, Felix Y., Schaeffer, Edward M., Spratt, Daniel E.

“…Molecular biomarkers aim to address the established limitations of clinicopathologic factors to accurately risk stratify patients with prostate cancer (PCa)…”
Get full text

Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer by Spratt, Daniel E, Alshalalfa, Mohammed, Fishbane, Nick, Weiner, Adam B, Mehra, Rohit, Mahal, Brandon A, Lehrer, Jonathan, Liu, Yang, Zhao, Shuang G, Speers, Corey, Morgan, Todd M, Dicker, Adam P, Freedland, Stephen J, Karnes, R Jeffery, Weinmann, Sheila, Davicioni, Elai, Ross, Ashley E, Den, Robert B, Nguyen, Paul L, Feng, Felix Y, Lotan, Tamara L, Chinnaiyan, Arul M, Schaeffer, Edward M

“…The heterogeneity of androgen receptor (AR)-activity (AR-A) is well-characterized in heavily treated metastatic castration-resistant prostate cancer (mCRPC)…”
Get full text

Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort by Weiner, Adam B, Cohen, Jason E, DeLancey, John O, Schaeffer, Edward M, Auffenberg, Gregory B

“…Surgical castration for metastatic prostate cancer is used less frequently than medical castration yet costs less, requires less followup and may be associated…”
Get full text

Reply to Zeynep G. Gul, Alberto Martini, and Carl A. Olsson's Letter to the Editor re: Jacob A. Burns, Adam B. Weiner, William J. Catalona, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846–52 by Burns, Jacob A., Weiner, Adam B., Kundu, Shilajit

Get full text

Inflammatory Bowel Disease and the Risk of Prostate Cancer by Burns, Jacob A., Weiner, Adam B., Catalona, William J., Li, Eric V., Schaeffer, Edward M., Hanauer, Stephen B., Strong, Scott, Burns, James, Hussain, Maha H.A., Kundu, Shilajit D.

“…There are limited data examining the risk of prostate cancer (PCa) in patients with inflammatory bowel disease (IBD). To compare the incidence of PCa between…”
Get full text

Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review by Weiner, Adam B., Kakani, Preeti, Armstrong, Andrew J., Bossi, Alberto, Cornford, Philip, Feng, Felix, Kanabur, Pratik, Karnes, R. Jeffery, Mckay, Rana R., Morgan, Todd M., Schaeffer, Edward M., Shore, Neal, Tree, Alison C., Spratt, Daniel E.

“…For patients with biochemical or local-regional recurrent prostate cancer, this work highlights risk factors for adverse cancer outcomes supported by…”
Get full text